![Hayden Malone: Ongoing efforts to target chromatin remodellers in cancer](https://oncodaily.com/pub/uploads/2024/07/Hayden-Malone-e1721573269790.jpeg)
Photo from Hayden Malone/LinkedIn
Jul 21, 2024, 15:21
Hayden Malone: Ongoing efforts to target chromatin remodellers in cancer
Hayden Malone, PhD Candidate at St. Jude Children’s Research Hospital, shared a post on LinkedIn:
”Delighted to share my first first-author manuscript published in Nature Reviews Drug Discovery. In this Review, Charles Roberts and I discuss ongoing efforts to target chromatin remodellers in cancer and other diseases, with a focus on SWI/SNF complexes. We also discuss efforts to leverage other synthetic lethalaties to treat the approximately 20% of all cancers that have mutations in SWI/SNF subunits.”
Chromatin remodellers as therapeutic targets.
Authors: Hayden A. Malone, Charles W. M. Roberts.
Source: Hayden Malone/LinkedIn
Aug 21, 2024, 15:04